Compile Data Set for Download or QSAR
Report error Found 108 Enz. Inhib. hit(s) with all data for entry = 9857
TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382491BDBM50382491(CHEMBL2024114 | US10988455, Example 1(xlii))
Affinity DataKi:  0.145nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493753BDBM493753(US10988455, Example 1(lxxix))
Affinity DataKi:  0.447nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493769BDBM493769(US10988455, Example 1(clxxx))
Affinity DataKi:  1.26nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382491BDBM50382491(CHEMBL2024114 | US10988455, Example 1(xlii))
Affinity DataKi:  1.38nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493775BDBM493775(US10988455, Example 1(ccxi))
Affinity DataKi:  1.82nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493770BDBM493770(US10988455, Example 1(clxxxi))
Affinity DataKi:  1.95nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493794BDBM493794(US10988455, Example 5(vii))
Affinity DataKi:  2.04nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382497BDBM50382497(CHEMBL2021950 | US10988455, Example 1(xli))
Affinity DataKi:  2.09nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493747BDBM493747(US10988455, Example 1(li))
Affinity DataKi:  2.19nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493776BDBM493776(US10988455, Example 1(ccxii))
Affinity DataKi:  2.19nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493768BDBM493768(US10988455, Example 1(clxxix))
Affinity DataKi:  2.40nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382498BDBM50382498(CHEMBL2024119 | US10988455, Example 1(ccix))
Affinity DataKi:  2.57nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493745BDBM493745(US10988455, Example 1(xliii))
Affinity DataKi:  2.88nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493750BDBM493750(US10988455, Example 1(lxxii))
Affinity DataKi:  3.02nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493798BDBM493798(US10988455, Example 5(x))
Affinity DataKi:  3.02nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493791BDBM493791(US10988455, Example 3(xxiv))
Affinity DataKi:  3.47nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493737BDBM493737(US10988455, Example 1(xv))
Affinity DataKi:  3.55nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493765BDBM493765(US10988455, Example 1(clxix))
Affinity DataKi:  3.98nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382489BDBM50382489(CHEMBL2024112 | US10988455, Example 1(xiii))
Affinity DataKi:  3.98nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382496BDBM50382496(CHEMBL2024120 | US10988455, Example 1(cxciii))
Affinity DataKi:  4.57nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493771BDBM493771(US10988455, Example 1(cxci))
Affinity DataKi:  5.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493749BDBM493749(US10988455, Example 1(lvi))
Affinity DataKi:  6.03nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493742BDBM493742(US10988455, Example 1(xxxv))
Affinity DataKi:  6.31nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382492BDBM50382492(CHEMBL2024115 | US10988455, Example 5(viii))
Affinity DataKi:  7.76nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493756BDBM493756(US10988455, Example 1(xc))
Affinity DataKi:  8.51nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382496BDBM50382496(CHEMBL2024120 | US10988455, Example 1(cxciii))
Affinity DataKi:  8.51nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493789BDBM493789(US10988455, Example 3(xxi))
Affinity DataKi:  8.51nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493798BDBM493798(US10988455, Example 5(x))
Affinity DataKi:  8.91nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493767BDBM493767(US10988455, Example 1(clxxvi))
Affinity DataKi:  9.33nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493740BDBM493740(US10988455, Example 1(xxiv))
Affinity DataKi:  9.33nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382495BDBM50382495(CHEMBL2024118 | US10988455, Example 1(clviii))
Affinity DataKi:  10.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382492BDBM50382492(CHEMBL2024115 | US10988455, Example 5(viii))
Affinity DataKi:  12.3nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493793BDBM493793(US10988455, Example 4(ii))
Affinity DataKi:  12.9nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493757BDBM493757(US10988455, Example 1(xcv))
Affinity DataKi:  13.8nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382497BDBM50382497(CHEMBL2021950 | US10988455, Example 1(xli))
Affinity DataKi:  14.8nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493735BDBM493735(US10988455, Example 1(ix))
Affinity DataKi:  15.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493764BDBM493764(US10988455, Example 1(clix))
Affinity DataKi:  15.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50011296BDBM50011296(CHEMBL3260728 | US10988455, Example 2(iv))
Affinity DataKi:  16.2nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493797BDBM493797(US10988455, Example 5(ix))
Affinity DataKi:  17nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493799BDBM493799(US10988455, Example 5(xi))
Affinity DataKi:  17.4nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493769BDBM493769(US10988455, Example 1(clxxx))
Affinity DataKi:  17.4nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493745BDBM493745(US10988455, Example 1(xliii))
Affinity DataKi:  18.2nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493775BDBM493775(US10988455, Example 1(ccxi))
Affinity DataKi:  19.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493735BDBM493735(US10988455, Example 1(ix))
Affinity DataKi:  20nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493776BDBM493776(US10988455, Example 1(ccxii))
Affinity DataKi:  20.9nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493797BDBM493797(US10988455, Example 5(ix))
Affinity DataKi:  24nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493760BDBM493760(US10988455, Example 1(cxxxiv))
Affinity DataKi:  24nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382498BDBM50382498(CHEMBL2024119 | US10988455, Example 1(ccix))
Affinity DataKi:  25.1nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A2a(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50382494BDBM50382494(CHEMBL2024117 | US10988455, Example 1(cliv))
Affinity DataKi:  27.5nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

TargetAdenosine receptor A1(Human)
Heptares Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 493768BDBM493768(US10988455, Example 1(clxxix))
Affinity DataKi:  30.2nMAssay Description:All test compounds were prepared as a stock solution of 10 mM in 100% DMSO.Inhibition binding assays were performed using 2.5 μg of membranes pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
US Patent

Displayed 1 to 50 (of 108 total ) | Next | Last >>
Jump to: